Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity

Mei-Mei Li(University of Cincinnati), Ai‐Ming Yu(University at Buffalo, State University of New York)
Drug Metabolism and Disposition
May 2, 2015
10.1124/dmd.115.064493
Cited by 60

Related Papers

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
|Journal of Pharmacology and Experimental Therapeutics|2018|68
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
|Drug Metabolism and Disposition|2017|62
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
|Scientific Reports|2016|43
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models
|Oncotarget|2017|29
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents
|RNA|2024|10